Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SSII · against 440 other Healthcare companies of similar size
Ranked #282 of 441 · scores higher than 11% of peers
Bars: peers in each 10-point band of the valuation score160 peers with a valuation score of 0–9, including SSII · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | SSII | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 428 reported | -2.6% | 0.4% | 39% | 30% | |
| EBITDA yieldHigher is better · 446 reported | -1.6% | 3.3% | 33% | 50% | |
| Free cash flow yieldHigher is better · 204 reported | -3.9% | -7.3% | 58% | 20% | |
| Book yieldHigher is better · 438 reported | 11.7% | 49.0% | 12% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 6.50T IDR (≈$403M) | 99 | 69 | |
| 282 | 673M USD | 8 | 35 | |
| 282 | 588M USD | 8 | 24 | |
| 282 | 303M USD | 8 | 27 | |
| 282 | 354M USD | 8 | 13 | |
| 282 | 467M USD | 8 | 44 | |
| 282 | 549M USD | 8 | 30 | |
| 282 | 371M USD | 8 | ||
| 282 | 394M USD | 8 | 37 | |
| 282 | 513M USD | 8 | 31 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score